about
The role of P2X7 receptors in tissue fibrosis: a brief reviewAlways cleave up your mess: targeting collagen degradation to treat tissue fibrosisLiver fibrosisCurrent status of novel antifibrotic therapies in patients with chronic liver diseaseRole of platelets in chronic liver disease and acute liver injury.Platelets in liver disease, cancer and regenerationCirrhosis and its complications: evidence based treatment.Neutrophil depletion blocks early collagen degradation in repairing cholestatic rat liversCombinatorial interactions of p53, activating protein-2, and YB-1 with a single enhancer element regulate gelatinase A expression in neoplastic cells.Non-invasive assessment of changes in liver fibrosis via liver stiffness measurement in patients with chronic hepatitis B: impact of antiviral treatment on fibrosis regression.Effects of adrenomedullin gene overexpression on biological behavior of hepatic stellate cells.Angiopoietin-1 causes reversible degradation of the portal microcirculation in mice: implications for treatment of liver disease.Regression of allograft airway fibrosis: the role of MMP-dependent tissue remodeling in obliterative bronchiolitis after lung transplantationNGF and P75NTR gene expression is associated with the hepatic fibrosis stage due to viral and non-viral causes.Antiviral therapy leads to histological improvement of HBeAg-negative chronic hepatitis B patients.Adeno-associated virus mediated interferon-gamma inhibits the progression of hepatic fibrosis in vitro and in vivo.Automated biphasic morphological assessment of hepatitis B-related liver fibrosis using second harmonic generation microscopyElastin Fiber Accumulation in Liver Correlates with the Development of Hepatocellular Carcinoma.Study on the Antifibrotic Effects of Recombinant Shark Hepatical Stimulator Analogue (r-sHSA) in Vitro and in Vivo.Effect of rat serum containing Biejiajian oral liquid on proliferation of rat hepatic stellate cellsATGL and CGI-58 are lipid droplet proteins of the hepatic stellate cell line HSC-T6Effect of caffeic acid phenethyl ester on proliferation and apoptosis of hepatic stellate cells in vitro.Establishment of an early liver fibrosis model by the hydrodynamics-based transfer of TGF-beta1 geneEffects of heparin on liver fibrosis in patients with chronic hepatitis B.Clinical observation of salvianolic acid B in treatment of liver fibrosis in chronic hepatitis B.Matrix metalloproteinases, the pros and cons, in liver fibrosisNOX in liver fibrosisMAPK Signal Transduction Pathway Regulation: A Novel Mechanism of Rat HSC-T6 Cell Apoptosis Induced by FUZHENGHUAYU TabletBioconjugation of oligonucleotides for treating liver fibrosis.Collagen-binding vascular endothelial growth factor attenuates CCl4-induced liver fibrosis in mice.Targeted RNA interference for hepatic fibrosis.Citrate functionalized Mn3O4 in nanotherapy of hepatic fibrosis by oral administration.Effects of silymarin and pentoxifylline on matrix metalloproteinase-1 and -2 expression and apoptosis in experimental hepatic fibrosis.Autophagy in hepatic fibrosis.Molecular serum markers of liver fibrosis.Factor VII activating protease (FSAP): a novel protective factor in liver fibrosis.Clinical application of transient elastography in patients with chronic viral hepatitis receiving antiviral treatment.Role of matrix metalloproteinases in cholestasis and hepatic ischemia/reperfusion injury: A review.The stellate cell system (vitamin A-storing cell system).Cytoglobin expression in the hepatic stellate cell line HSC-T6 is regulated by extracellular matrix proteins dependent on FAK-signalling.
P2860
Q26796346-639F7FF1-A985-419B-96F9-F2BFD9416297Q26827393-E43D9435-8672-4F58-A307-224901D3CF1DQ29547449-65308891-6318-4ADB-B032-EF0F66E76E10Q30473375-AE4AF91B-6550-4D51-BD8C-235448D264E4Q33409013-DBD92469-2BFD-42D3-BF2F-79BE6C764806Q33442308-0A15F132-95B5-4DDC-BB55-249219CEE389Q33594931-6A4EA98F-F4A0-4BB2-8003-274B5BEAC168Q33703705-E62E9C92-0310-48B1-A897-B76DE261BCEDQ34125244-96DC9D37-DF25-451C-BE49-E7A473EC3BD3Q34365464-259D31A3-113E-44B0-98B0-6CD0DA282AD9Q35045237-B692D1B1-586E-487C-876A-F117774CE44CQ35103148-1A77EB99-B634-4060-A1B0-9C60BBE613C2Q35168136-F3D3FD27-1FA8-4BAF-B956-35B64EE4EC2CQ35225194-664CA7DE-5D55-4E35-B6BB-5175F057B150Q35779487-F8AC4538-E5DF-4D9D-A723-3CD64CB20BA7Q35851146-94846A6E-BE81-4B6E-9581-2A76D0734A6EQ35936165-909D1A46-A31F-4B04-A71A-F2944941CE91Q36003201-2CB50034-80ED-4F84-9B74-A1DA9A657C89Q36018045-A1B7E923-6209-4B51-AAEB-BE645A1B48F8Q36065884-508D6C6D-0327-4E40-B322-5B1B76A73C43Q36093217-CBB21B30-380D-4ECD-A712-C1CEEE5605EFQ36179842-00A18E0D-3FD7-49FC-9B73-EABD1C54E8F9Q36183787-165E37E5-0046-42EF-83C7-B617B3015737Q36190788-07412DFF-5725-4D2F-A8BF-21DB4F10644EQ36308206-55B31F66-ABA6-430A-95B3-5406629EC6CAQ36588247-21F80DF6-BD66-46CC-9E0D-0B77B1097F32Q36832562-94EDF2C3-4312-42AA-B9B2-BFFE51AC90B0Q36896262-EAD5BA57-9D22-4FFD-9473-441B828E110EQ37043515-0384FF11-CD65-478D-9463-8954B3727F83Q37403606-CF3B7BF0-FEF5-465F-8245-1A3CDC4EAEE1Q37590368-F3AA090E-FCD4-4881-90A3-877CF9167D53Q37591874-536881F3-2E30-4290-8B1B-2C4B34C17109Q37672866-23584BC5-EA1E-4106-9E6A-53BC7AED05E8Q37693729-18021540-8FD1-4B36-BB8F-05CC617A5CF6Q38032835-2F9752AA-BB8F-4ED5-BA63-9550336765B6Q38185361-7709067B-60BE-4232-A084-95848BEC5E3BQ38224416-49FE9B54-A5B9-4F1E-A34F-A9F6A171F93AQ38635618-5429A386-FDC2-420D-AA05-EA19F340AE48Q38744473-E7ED4793-054A-4566-8146-E4957616801DQ38841405-C5CF2D5D-EB3F-4936-B659-B31CF1E6612B
P2860
description
2000 nî lūn-bûn
@nan
2000 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Is liver fibrosis reversible?
@ast
Is liver fibrosis reversible?
@en
type
label
Is liver fibrosis reversible?
@ast
Is liver fibrosis reversible?
@en
prefLabel
Is liver fibrosis reversible?
@ast
Is liver fibrosis reversible?
@en
P2860
P356
P1433
P1476
Is liver fibrosis reversible?
@en
P2093
P2860
P304
P356
10.1136/GUT.46.4.443
P407
P577
2000-04-01T00:00:00Z